Guideline for switching pregabalin to gabapentin, including dosage, renal adjustments, titration, and cost. An overview of possible dose equivalences, switching methods and considerations to make before switching between gabapentinoids in adults with neuropathic pain. An article from the musculoskeletal medicine section of GPnotebook: Switching between gabapentin and pregabalin for neuropathic pain. From the Guidelines To convert Lyrica (pregabalin) 50 mg BID to gabapentin, I recommend starting with gabapentin 300 mg three times daily (900 mg total daily dose). This conversion is based on the general principle that pregabalin is approximately 6 times more potent than gabapentin, making 100 mg of pregabalin (50 mg BID) roughly equivalent to 600-900 mg of gabapentin daily 1. Gabapentin The bioavailability of generic gabapentin in tablet and capsule formulations equivalent to brand-name Neurontin is about 80% at lower doses such as 100 mg every 8 hours, but only 27% bioavailable at doses of 1600 mg every 8 hours. 3,4 This differs greatly from pregabalin, which boasts a greater than 90% bioavailability across a dosage range Conversion of Gabapentin to Pregabalin In a previous post, I discussed the rare situation of patients being on both gabapentin and pregabalin and some possible explanations for this scenario. That prompted someone to ask me how to do a conversion of gabapentin to pregabalin. Starting Doses in Neuropathic Pain The recommended starting dose of gabapentin is 300 mg once daily on day 1, then 300 mg twice daily on day 2, then 300 mg three times a day on day 3.1,5 Lower doses should be used in older patients with renal impairment.1 In practice, lower doses and slower titration of gabapentin is often considered. Discontinuation symptoms reported include insomnia, nausea, anxiety, pain, and sweating.4 Determining dose equiva-lence between gabapentin and pregabalin is complicated by gabapentin’s nonlinear bioavailability, in contrast to pregaba-lin’s linear bioavailability.6 Gabapentin’s bioavailability ranges from 80% with 100mg tds6 to 35% with 1 Conversion between Lyrica and gabapentin is generally Daily Dose of Daily Dose of Shingrix well tolerated and direct switching minimizes potential for Gabapentin Lyrica Reactogenicity gaps in pain relief. Finally, a trial by Toth C. utilized a conversion algorithm that roughly equates to a gabapentin-to-pregabalin ratio of 6:1. 3 Response Because BT was taking 1800 mg of Neurontin® daily at the time, I recommended that Lyrica® be started at 150 mg BID. This document provides guidance on converting patients from pregabalin to gabapentin, including recommended total daily doses of gabapentin based on pregabalin dose. It also includes information on titrating the gabapentin dose, adjusting the dose based on renal function, standard and rapid titration schedules for gabapentin, maximum doses, and discontinuing gabapentin gradually over a week. 150 mg Lyrica (pregabalin) and gabapentin are widely prescribed medications that share similarities in treating nerve-related conditions, but they differ in potency and pharmacodynamics. Patients switching between these medications often need clarity on equivalent dosing to ensure effective symptom management without adverse effects. This article explores the approximate equivalence between Discontinuation symptoms reported include insomnia, nausea, anxiety, pain, and sweating.4 Determining dose equiva-lence between gabapentin and pregabalin is complicated by gabapentin’s nonlinear bioavailability, in contrast to pregaba-lin’s linear bioavailability.6 Gabapentin’s bioavailability ranges from 80% with 100mg tds6 to 35% with 1 The second method proposed was a cross-titration where 50% of the existing gabapentin dose was co-administered with 50% of the new pregabalin dose for four days, then the full pregabalin dose was initiated and gabapentin was completely discontinued. 15 The transitions were studied at three dosages using a 6:1 conversion (Table 2). Understanding Gabapentin and Lyrica Gabapentin and Lyrica (pregabalin) are both medications primarily used to treat nerve pain, seizures, and other conditions. While they share similar mechanisms of action, they differ significantly in their formulations, dosing, and side effects. Lyrica, does have abuse potential. This reinforces the importance of ensuring each patient taking gabapentin has an appropriate indication, dose and frequency to maximize benefit Studies show minimal benefit & more adverse effects when high Lyrica doses are used for diabetic neuropathy (>300 mg/day) and fibromyalgia (>450 mg/day) Transition from gabapentin to pregabalin was seamless and rapid, with predicted pregabalin-equivalent concentrations highly comparable with plasma pregabalin concentrations within 1 day of pregabalin initiation in the immediate discontinuation model and within 1 day of gabapentin cessation in the gradual discontinuation model. There are no validated dose conversions between gabapentin and pregabalin due to differences in pharmacokinetics and varying efficacy seen in studies. However, some authors have proposed dose conversions based on these parameters (see Tables 1 and 2). One switching method suggests daily doses of gabapentin between 901 to 1,500 mg/day should be converted to pregabalin 225 mg/day in two divided If using the 6:1 ratio of gabapentin to pregabalin dosing, it is important to note that at some dose ranges, this conversion may be too conservative whereas at other doses/situations it may be too aggressive. Discontinuation symptoms reported include insomnia, nausea, anxiety, pain, and sweating.4 Determining dose equiva-lence between gabapentin and pregabalin is complicated by gabapentin’s nonlinear bioavailability, in contrast to pregaba-lin’s linear bioavailability.6 Gabapentin’s bioavailability ranges from 80% with 100mg tds6 to 35% with 1
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |